Drug Pipeline

REGN7075 Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
4
Active Studies
3
Recruiting
2
Top Sponsors
Active Studies by Phase
Phase 2
3
Phase 1/2
1
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT06465329 A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other… Non-Small Cell Lung Cancer Recruiting
NCT07154290 A Study to Investigate Ubamatamab With and Without REGN7075 in Adult Participants With… Advanced/Metastatic Non-Small Cell Lung Cancer Recruiting
NCT07281768 Capecitabine/Oxaliplatin Chemotherapy and Cemiplimab With or Without Fianlimab or… Colorectal Cancer Not Yet Recruiting
Phase 1/2
NCT04626635 A Trial to Find Out How Safe REGN7075 is and How Well it Works in Combination With… Advanced Solid Tumors Recruiting
Sponsors Running REGN7075 Trials
Regeneron Pharmaceuticals (3) Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (2) Lung Cancer (2) Colorectal Cancer (1)
Get alerts when REGN7075 trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free